Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

What does postprandial hyperglycaemia mean?

R J Heine1, B Balkau, A Ceriello

  • 1Panel Chair, Diabetes Centre, VU University Medical Centre, Amsterdam, the Netherlands. rj.heine@vumc.nl

Diabetic Medicine : a Journal of the British Diabetic Association
|March 11, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A prediction model to assess the risk of egfr loss in patients with type 2 diabetes and preserved kidney function: The amd annals initiative.

Diabetes research and clinical practice·2022
Same author

COVID-19 in people living with diabetes: An international consensus.

Journal of diabetes and its complications·2020
Same author

Increased risk of type 2 diabetes in antidepressant users: evidence from a 6-year longitudinal study in the E3N cohort.

Diabetic medicine : a journal of the British Diabetic Association·2020
Same author

Learning about diabetes through epidemiology.

Diabetic medicine : a journal of the British Diabetic Association·2020
Same author

Dairy consumption is associated with lower plasma dihydroceramides in women from the D.E.S.I.R. cohort.

Diabetes & metabolism·2019
Same author

Triple-layer Mesh Plasty for Re-recurrent Ventral Hernia in a Liver Transplant Patient: A Case Report.

Transplantation proceedings·2019
Same journal

Prevalence, duration, and clinical implications of continuous glucose monitor measurement limit capping in type 1 diabetes.

Diabetic medicine : a journal of the British Diabetic Association·2026
Same journal

Disentangling the effect of brain insulin resistance on brain health (BIR-BrainHealth): Rationale and study protocol.

Diabetic medicine : a journal of the British Diabetic Association·2026
Same journal

Clinical characteristics and in-hospital mortality among insulin pump users with acute coronary syndrome in the predominantly open-loop era: A UK-wide MINAP registry analysis.

Diabetic medicine : a journal of the British Diabetic Association·2026
Same journal

Hyperlipidaemia in youth with type 1 diabetes: Are current guidelines clinically useful?

Diabetic medicine : a journal of the British Diabetic Association·2026
Same journal

Hypoglycaemia care: Time to modernise our treatment standards.

Diabetic medicine : a journal of the British Diabetic Association·2026
Same journal

Continuing automated insulin delivery systems during hospitalisation with type 1 diabetes: A thematic literature review.

Diabetic medicine : a journal of the British Diabetic Association·2026
See all related articles

Controlling postprandial glucose (PPG) and metabolic syndrome components is crucial for preventing diabetic complications. Managing both acute and chronic glucose fluctuations, along with triglycerides, reduces micro- and macrovascular risks in Type 2 diabetes.

Area of Science:

  • Endocrinology
  • Metabolic Disorders
  • Cardiovascular Disease

Background:

  • The role of postprandial glucose (PPG) in Type 2 diabetes complications is debated.
  • Recent guidelines highlight the need to examine PPG excursions and cardiovascular disease (CVD) risk factors.
  • The metabolic syndrome is a significant risk factor for CVD morbidity and mortality.

Purpose of the Study:

  • To review the role of PPG in the context of metabolic syndrome and Type 2 diabetes complications.
  • To incorporate recent ADA and American College of Endocrinology guidelines.
  • To evaluate the contributions of PPG, metabolic syndrome, and triglycerides to cardiovascular complications.

Main Methods:

  • Expert panel review.
  • Discussion based on ADA consensus statement and AACE guidelines.

Related Experiment Videos

  • Focus on postprandial hyperglycemia, metabolic syndrome, and triglyceride levels.

    • Main Results:

    • Postprandial hyperglycemia indicates risk for micro- and macrovascular complications in Type 2 diabetes and impaired glucose tolerance.
    • Metabolic syndrome increases CVD morbidity and mortality risk.
    • Debate centered on the relative impact of PPG, metabolic syndrome, and postprandial triglycerides on CVD.

    Conclusions:

    • Targeting both chronic and acute glucose fluctuations is essential for preventing microvascular complications in Type 2 diabetes.
    • Controlling postprandial triglyceride levels and other metabolic syndrome components is necessary to lower macrovascular risk.